North America dominates the Cerebral Oxygen Saturation Monitor market growth, accounting for 40% of global demand. Key drivers include high adoption of advanced neurocritical care technologies, robust R&D investments, and stringent regulatory frameworks promoting patient safety. The aging population and rising incidence of traumatic brain injuries further fuel demand. Europe follows at 25%, driven by mature healthcare ecosystems, strong policy support for early diagnosis, and growing awareness of stroke prevention. Asia Pacific is the fastest-growing region, projected to capture 20% by 2025, propelled by expanding healthcare infrastructure, rising disposable incomes, and increased focus on neurological disorder management. Latin America (10%) benefits from public-private partnerships and improved access to diagnostics, while Middle East & Africa (5%) sees growth from urbanization-driven healthcare modernization and rising investment in critical care facilities.